Hanoi, August 11, 2025 – In the context of Vietnam’s veterinary pharmaceutical industry facing a strong wave of integration, with the entry of numerous international corporations and increasingly stringent export market requirements for quality standards and traceability, two long-standing Vietnamese veterinary pharmaceutical brands – Central Veterinary Medicine Joint Stock Company No. 1 (Vinavetco) and Cai Lay Veterinary Pharmaceutical Joint Stock Company (Mekovet) – have decided to join forces in a strategic business alliance, officially establishing the Vietnam Veterinary Pharmaceutical Group, effective from August 11, 2025.
With the motto “For Community Health”, Vinavetco, established in 1973, has a strong scientific foundation and strengths in injectable drugs and vaccines, supported by a state-owned network of production, distribution, and R&D facilities spanning the northern region.
Meanwhile, Mekovet – “A trusted brand known everywhere”, founded in 1990, represents the dynamic South, pioneering the application of modern technologies, with competitive advantages in premix, soluble powder, injectable antibiotics, and a broad private distribution network across southern Vietnam.
The unification of these two long-standing brands is not simply the merger of two companies, but the integration of two heritages, two strategic market regions – North and South – and two complementary strengths, aiming to create a stronger organization capable of providing comprehensive solutions and leading the market.
Building a Leading National Veterinary Pharmaceutical Group with Regional Reach
The merger aims to establish a comprehensive, modern, and stronger veterinary pharmaceutical ecosystem. This alliance will enhance overall capabilities – from product research and development to production and distribution – ensuring superior competitiveness in an increasingly demanding and volatile market. The consolidation will also optimize distribution channels nationwide, creating a unified network from North to South, improving customer service efficiency, shortening market access time, and increasing operational flexibility.
The unification will significantly strengthen competitiveness, especially amid deepening integration, where global corporations are expanding into Vietnam. Instead of competing separately, the alliance allows the two brands to fully leverage their complementary advantages – together forming a powerful synergy.
It is also an opportunity to optimize resources, creating a highly unified organization ready for digital transformation and international expansion in the near future. This is the foundation to realize the long-term goal of building a leading veterinary pharmaceutical group in Vietnam with a strong presence in the Southeast Asian region.
Development Roadmap and New Vision
Following its launch, the Vietnam Veterinary Pharmaceutical Group has set ambitious goals: becoming the industry leader with a standardized management system under GMP-WHO and ISO 22000. The Group will immediately implement the advanced SAP S/4HANA enterprise resource planning software and make significant investments in key areas, including: planning a vaccine manufacturing facility, developing next-generation antibiotics, herbal-based biological products, functional nutrition for livestock, establishing a dedicated R&D innovation center, and expanding international markets...
The launch of the Vietnam Veterinary Pharmaceutical Group marks not only the unification of two long-standing brands but also a milestone that opens a promising new chapter for Vietnam’s veterinary pharmaceutical industry.
Speaking at the event, Mr. David John Whitehead – Chairman of Mavin Group, which acted as strategic advisor and supporter throughout the process, connecting, shaping the vision, and accompanying the creation of the new organizational model, shared:
“We are honored to accompany Vinavetco and Mekovet in this highly strategic transformation. This unification not only creates a stronger organization but also demonstrates a commitment to shaping the future of Vietnam’s livestock industry with comprehensive, sustainable, and forward-looking solutions. I believe this will lay the foundation for the Vietnam Veterinary Pharmaceutical Group to lead the domestic market and gradually conquer international markets.”
In the context of livestock and aquaculture industries demanding higher standards of quality, safety, and efficiency, the establishment of the Vietnam Veterinary Pharmaceutical Group is expected to drive innovation and form a leading enterprise in the sector. This is not just the combination of two companies but the intersection of heritage and innovation, traditional strength and the aspiration for growth. With a solid foundation, strategic vision, and advisory support from Mavin, the Vietnam Veterinary Pharmaceutical Group is poised to become a new symbol of sustainable development, resilience, and integration in Vietnam’s veterinary pharmaceutical industry.